Search results
Stock Market Eyes Fear Gauge Ahead Of Fed; This Biotech Nears Major Breakout: AMD Could Sink Chips
Investor's Business Daily· 1 year agoMajor stock market indexes bounced Tuesday while investors squared positions ahead of Wednesday's...
Stock Market Ends Upbeat Week With Mixed Results On Hot Job Numbers
Investor's Business Daily· 2 years agoThe stock market closed mixed on Friday but narrow losses failed to erase big gains posted earlier...
Here's How Much a $1000 Investment in Ligand Pharmaceuticals Made 10 Years Ago Would Be Worth Today
Zacks via Yahoo Finance· 1 year agoHow much a stock's price changes over time is a significant driver for most investors. Not only can...
Pharma Stock Roundup: JNJ, NVS Q2 Earnings, GSK Consumer Unit Spin-Off
Zacks via Yahoo Finance· 2 years agoThis week, J&J JNJ set in motion the second-quarter earnings season for the drug and biotech sector...
Pharma Stock Roundup: AZN, SNY, ABBV Q2 Results, MRK, MRNA Cancer Jab in Phase III
Zacks via Yahoo Finance· 10 months agoThis week, AstraZeneca AZN, Sanofi SNY and AbbVie ABBV and Roche announced second-quarter earnings....
Should You Buy Physicians Realty Trust Before It Merges With Healthpeak?
Motley Fool· 7 months agoPhysicians Realty Trust (NYSE: DOC) investors woke up to some surprising news recently. The real...
Pharma Stock Roundup: MRK & Others Post Q1 Results, LLY Drug Shines in Obesity Study
Zacks via Yahoo Finance· 1 year agoMerck (MRK), Eli Lilly (LLY), AstraZeneca (AZN) and others report first-quarter results. J&J (JNJ)...
Dow Jones Slides On Key Economic Data. Fed Meeting Begins, While Tesla Rallies On Price Hikes.
Investor's Business Daily· 1 year agoThe Dow Jones Industrial Average sold off 300 points Tuesday after key economic data, led by factory...
Dow Jones Rallies 250 Points As Netflix, Tesla Earnings Loom; Apple Falls On iPhone 15 News
Investor's Business Daily· 8 months agoThe Dow Jones Industrial Average rallied more than 250 points Monday ahead of a big week of earnings...
Just Say No to Drugs: 3 Pharma Stocks to Avoid
InvestorPlace via Yahoo Finance· 1 month agoFrom its stellar performance in 2021 to deflating in 2022, the biotech sector continued its stagnation into 2023, highlighting some pharma stocks to...